Deutsche Bank
SUPN icon

Deutsche Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Deutsche Bank’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-455
Closed -$13K – 4257
2021
Q4 		$13K Buy
455
+224
+97% +$6.8K ﹤0.01% 4150
2021
Q3 		$6K Sell
231
-6
-3% -$161 ﹤0.01% 4327
2021
Q2 		$7K Buy
+237
New +$7.27K ﹤0.01% 4487
2020
Q4 		– Sell
-200
Closed -$4K – 4522
2020
Q3 		$4K Buy
+200
New +$4.54K ﹤0.01% 4266

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's SUPN Position: Q1 2026 in Review

Deutsche Bank increased its Supernus Pharmaceuticals (SUPN) stake by 4.6% in Q1 2026, buying an estimated $266K and bringing the position to 118,550 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Deutsche Bank first reported a position in SUPN in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.2M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Deutsche Bank held 118,550 shares of Supernus Pharmaceuticals worth $6.13M as of Q1 2026.
  • Deutsche Bank bought 5,231 Supernus Pharmaceuticals shares in Q1 2026, an estimated $266K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1219 holding.
  • Deutsche Bank first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Supernus Pharmaceuticals position peaked at $48.2M in Q2 2018.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.